Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Muscle Atrophy: early-phase trial registry

7 of 12 indexed Muscle Atrophy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 7 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Muscle Atrophy: 12 US clinical trials tracked, 7 recruiting.

Muscle Atrophy is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Tufts Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition muscle-atrophy

OPEN 7 | RECR 58% | LATE 0 | EARLY 5 | RANK #1429 | SPON 2

Nearest open-share peer: Anterior Cruciate Ligament Reconstruction (58% recruiting · 12 trials)

Muscle Atrophy (this)58%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Muscle Atrophy

Muscle Atrophy lists 7 open slots (58% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Muscle Atrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Muscle Atrophy is recruiting above its size-band peers.

    7 of 12 indexed trials (58.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Muscle Atrophy research.

    Tufts Medical Center accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Most Muscle Atrophy trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 12 trials that report a genuine target (sentinel values excluded). 11 of those (91.7%) plan for fewer than 100 participants.

  4. Muscle Atrophy research is mostly interventional.

    11 interventional and 1 observational studies make up this index (91.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 22

Open and recent trials

12 total, page 1 of 1

RECRUITING NA 120 participants

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Tufts Medical Center

NCT05627440

RECRUITING 60 participants

Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure

Tufts Medical Center

NCT06253104

RECRUITING Phase 2 60 participants

Essential Amino Acid Supplementation for Femoral Fragility Fractures

Michael C Willey

NCT06050668

RECRUITING NA 50 participants

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

AdventHealth Translational Research Institute

NCT03761446

RECRUITING NA 30 participants

Impact of NMES and HPRO on Recovery After SAH- Pilot Study

University of Maryland, Baltimore

NCT03201094

RECRUITING Phase 1 28 participants

Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.

Immunis

NCT05211986

RECRUITING NA 16 participants

FIT Exercise in 30d of ULLS-induced Muscle Disuse

Lance Bollinger

NCT06631053

ACTIVE NOT RECRUITING Early Phase 1 64 participants

Role of Metformin on Muscle Health of Older Adults

University of Utah

NCT03107884

ACTIVE NOT RECRUITING Phase 2 56 participants

Stromal Vascular Fraction Cell Therapy to Improve the Repair of Rotator Cuff Tears

Hospital for Special Surgery, New York

NCT03332238

ACTIVE NOT RECRUITING NA 25 participants

Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome

Bijan Najafi, PhD

NCT06238609

ACTIVE NOT RECRUITING NA 20 participants

The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture

University of Alabama at Birmingham

NCT04809714

COMPLETED Phase 1 19 participants

Electrical Stimulation for Critically Ill Covid-19 Patients

Baylor College of Medicine

NCT04685213

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 2

Named interventions

Most-linked intervention names on Muscle Atrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Electrical Stimulation - Sham Device
1 trials
Ringer's solution Device
1 trials
Autologous Stomal Vascular Fraction Material Device
1 trials
Control Group Device
1 trials
Intervention Group Device
1 trials
Routine Post-operative Physical Therapy Other
1 trials
Blood Flow Restriction with Delfi Tourniquet System Cuff Device
1 trials
Placebo (2 week run-in only) Drug
1 trials

US sites by state

Facility locations filed on Muscle Atrophy trials. A trial with sites in several states counts in each.

Texas 2 trials
Massachusetts 2 trials
Utah 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Maryland 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Muscle Atrophy page

12 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscle Atrophy condition card totals 12 registered trials; most-linked intervention Electrical Stimulation - Sham; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.